0001104659-24-094012.txt : 20240828 0001104659-24-094012.hdr.sgml : 20240828 20240828163100 ACCESSION NUMBER: 0001104659-24-094012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240826 FILED AS OF DATE: 20240828 DATE AS OF CHANGE: 20240828 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TETRAULT LYNN A. CENTRAL INDEX KEY: 0001645512 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38223 FILM NUMBER: 241255941 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001649904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 462159271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-264-4280 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: RHYTHM METABOLIC, INC. DATE OF NAME CHANGE: 20150803 4 1 tm2422915-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-08-26 0 0001649904 RHYTHM PHARMACEUTICALS, INC. RYTM 0001645512 TETRAULT LYNN A. 222 BERKELEY STREET, 12TH FLOOR BOSTON MA 02116 1 0 0 0 1 Common Stock 2024-08-26 4 M 0 4300 18.99 A 7300 D Common Stock 2024-08-26 4 S 0 4300 50.0067 D 3000 D Stock Option (right to buy) 18.99 2024-08-26 4 M 0 4300 0.00 D 2031-06-08 Common Stock 4300 10700 D The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 13, 2024. The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $50.00 to $50.03. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. The option is fully vested and exercisable. /s/ Hunter Smith, attorney-in-fact for Lynn A. Tetrault 2024-08-28